Signaling pathways and late‐onset gene induction associated with renal mesangial cell hypertrophy
暂无分享,去创建一个
[1] J. Dagorn,et al. The HMG-I/Y-related Protein p8 Binds to p300 and Pax2trans-Activation Domain-interacting Protein to Regulate thetrans-Activation Activity of the Pax2A and Pax2B Transcription Factors on the Glucagon Gene Promoter* , 2002, The Journal of Biological Chemistry.
[2] M. Mussap,et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. , 2002, Kidney international.
[3] R. Feil,et al. p8-deficient fibroblasts grow more rapidly and are more resistant to adriamycin-induced apoptosis , 2002, Oncogene.
[4] J. Dagorn,et al. p8 is critical for tumour development induced by rasV12 mutated protein and E1A oncogene , 2002, EMBO reports.
[5] E. Olson,et al. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Iovanna,et al. Cloning and expression of the human p8, a nuclear protein with mitogenic activity. , 2001, European journal of biochemistry.
[7] David W. Anderson,et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] B. Hemmings,et al. Ten years of protein kinase B signalling: a hard Akt to follow. , 2001, Trends in biochemical sciences.
[9] J. Woodgett,et al. PKB/AKT: functional insights from genetic models , 2001, Nature Reviews Molecular Cell Biology.
[10] F Vinicor,et al. The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.
[11] D R Alessi,et al. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.
[12] Marc Montminy,et al. Transcriptional regulation by the phosphorylation-dependent factor CREB , 2001, Nature Reviews Molecular Cell Biology.
[13] T. Tuschl,et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.
[14] J. Iovanna,et al. Overexpression of p8 is inversely correlated with apoptosis in pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] J. Avruch,et al. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.
[16] R. Morimoto,et al. Bag1–Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth , 2001, Nature Cell Biology.
[17] J. Neal,et al. Glycogen Synthase Kinase-3 Inhibits the DNA Binding Activity of NFATc* , 2001, The Journal of Biological Chemistry.
[18] M. E. Ruaro,et al. Gas6 Induces Growth, β-Catenin Stabilization, and T-Cell Factor Transcriptional Activation in Contact-Inhibited C57 Mammary Cells , 2001, Molecular and Cellular Biology.
[19] J. Iovanna,et al. Expression of p8 in human pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] J. González-Ros,et al. Human p8 Is a HMG-I/Y-like Protein with DNA Binding Activity Enhanced by Phosphorylation* , 2001, The Journal of Biological Chemistry.
[21] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[22] T. Tuschl,et al. RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.
[23] R. Kitsis,et al. The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice , 2000, The EMBO journal.
[24] John C. Lee,et al. Extracellular Signal-regulated Kinase Plays an Essential Role in Hypertrophic Agonists, Endothelin-1 and Phenylephrine-induced Cardiomyocyte Hypertrophy* , 2000, The Journal of Biological Chemistry.
[25] B. Burgering,et al. Forkhead transcription factors are targets of signalling by the proto‐oncogene PKB (C‐AKT) , 2000, Journal of anatomy.
[26] J. Molkentin. Calcineurin and beyond: cardiac hypertrophic signaling. , 2000, Circulation research.
[27] J. Woodgett,et al. Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy , 2000, The Journal of cell biology.
[28] P. Cohen,et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors , 2000 .
[29] K. Mostov,et al. Membrane traffic in polarized epithelial cells. , 2000, Current opinion in cell biology.
[30] J. Bonventre,et al. Gene 33/Mig-6, a Transcriptionally Inducible Adapter Protein That Binds GTP-Cdc42 and Activates SAPK/JNK* , 2000, The Journal of Biological Chemistry.
[31] M. Bogoyevitch. Signalling via stress-activated mitogen-activated protein kinases in the cardiovascular system. , 2000, Cardiovascular research.
[32] E. Hovig,et al. Expression of a novel factor in human breast cancer cells with metastatic potential. , 1999, Cancer research.
[33] J. Guerrero,et al. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun NH(2)-terminal kinases. , 1999, The Journal of clinical investigation.
[34] John Calvin Reed,et al. An Evolutionarily Conserved Family of Hsp70/Hsc70 Molecular Chaperone Regulators* , 1999, The Journal of Biological Chemistry.
[35] R. Hajjar,et al. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. , 1998, The Journal of clinical investigation.
[36] D. Alessi,et al. Mitogen‐ and stress‐activated protein kinase‐1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB , 1998, The EMBO journal.
[37] J. Bonventre,et al. Mitogen‐activated protein kinases and transcriptional responses in renal injury and repair , 1998, Current opinion in nephrology and hypertension.
[38] Jeffrey Robbins,et al. A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.
[39] G. Bokoch,et al. Human myosin-IXb is a mechanochemically active motor and a GAP for rho. , 1998, Journal of cell science.
[40] Jiahuai Han,et al. Cardiac Hypertrophy Induced by Mitogen-activated Protein Kinase Kinase 7, a Specific Activator for c-Jun NH2-terminal Kinase in Ventricular Muscle Cells* , 1998, The Journal of Biological Chemistry.
[41] A. Hall,et al. Rho GTPases and the actin cytoskeleton. , 1998, Science.
[42] J Ross,et al. Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.
[43] J. Iovanna,et al. Cloning and Expression of the Rat p8 cDNA, a New Gene Activated in Pancreas during the Acute Phase of Pancreatitis, Pancreatic Development, and Regeneration, and Which Promotes Cellular Growth* , 1997, The Journal of Biological Chemistry.
[44] Colin B. Reese,et al. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase , 1997, Current Biology.
[45] E. Ruaro,et al. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts , 1997, Molecular and cellular biology.
[46] O. Kranenburg,et al. Identification of a Novel, Putative Rho-specific GDP/GTP Exchange Factor and a RhoA-binding Protein: Control of Neuronal Morphology , 1997, The Journal of cell biology.
[47] P. Cohen,et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Bα , 1997, Current Biology.
[48] P. Cohen,et al. Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.
[49] L Timmermann,et al. The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.
[50] P. Cohen,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.
[51] M. Simon,et al. Activation of phospholipase C beta 4 by heterotrimeric GTP-binding proteins. , 1994, The Journal of biological chemistry.
[52] H. Abboud,et al. Platelet derived growth factor-A chain gene expression in cultured mesangial cells: Regulation by phorbol ester at the level of mRNA abundance, transcription and mRNA stability , 1993, Molecular and Cellular Endocrinology.
[53] Tony Hunter,et al. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity , 1991, Cell.
[54] H. Abboud,et al. Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Kreisberg,et al. Vasoactive agents affect mesangial cell adhesion. , 1986, The American journal of physiology.
[56] J. Epstein,et al. Getting your Pax straight: Pax proteins in development and disease. , 2002, Trends in genetics : TIG.
[57] John F. Timms,et al. Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer , 2001 .
[58] K. Okkenhaug,et al. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. , 2001, Annual review of cell and developmental biology.
[59] J. Woodgett. Protein kinase functions , 2000 .
[60] R. Hajjar,et al. Signaling pathways mediating the response to hypertrophic stress in the heart. , 1999, Gene expression.
[61] P. Hogan,et al. Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.
[62] B. Hosler,et al. Copper/zinc superoxide dismutase mutations and free radical damage in amyotrophic lateral sclerosis. , 1995, Advances in neurology.